Interdisciplinary Autoimmune Summit

Interdisciplinary Autoimmune Summit

Source:

Cheifetz AS, Merola JF, Patel-Cohen M. Welcome remarks. Presented at: Interdisciplinary Autoimmune Summit; July 10-12, 2020 (virtual meeting).

Disclosures: Cheifetz reports consulting for Abbvie, Arena, Grifols, Janssen, Pfizer, Prometheus, Samsung and Takeda, Pfizer; and receiving research support from Inform Diagnostics. Merola reports being a consultant and/or investigator for Abbvie, Arena, Avotres, Biogen, Celgene, Dermavant, Eli Lilly, EMD Serono, Janssen, Leo Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi and Sun Pharma. Patel reports consulting for Abbvie, Eli Lilly and Janssen; and being on the speaker’s bureau of AbbVie and Eli Lilly.
July 10, 2020
2 min read
Save

‘Heavier workload’ in autoimmune care amid COVID-19 begs for interdisciplinary teamwork

Source:

Cheifetz AS, Merola JF, Patel-Cohen M. Welcome remarks. Presented at: Interdisciplinary Autoimmune Summit; July 10-12, 2020 (virtual meeting).

Disclosures: Cheifetz reports consulting for Abbvie, Arena, Grifols, Janssen, Pfizer, Prometheus, Samsung and Takeda, Pfizer; and receiving research support from Inform Diagnostics. Merola reports being a consultant and/or investigator for Abbvie, Arena, Avotres, Biogen, Celgene, Dermavant, Eli Lilly, EMD Serono, Janssen, Leo Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi and Sun Pharma. Patel reports consulting for Abbvie, Eli Lilly and Janssen; and being on the speaker’s bureau of AbbVie and Eli Lilly.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In the face of the unique threat that COVID-19 poses to patients with autoimmune diseases, communication across disciplines is essential “as our fields increasingly blend together,” noted presenters at the 2020 Interdisciplinary Autoimmune Summit.

Joseph F. Merola

In his opening remarks, conference chair Joseph F. Merola, MD, MMSc, director of the Center for Skin and Related Musculoskeletal Diseases at Brigham and Women's Hospital in Boston, was impressed by the continued growth of the meeting since its inception.

Communication across disciplines treating autoimmune populations is essential “as our fields increasingly blend together,” noted a presenter at the 2020 Interdisciplinary Autoimmune Summit.
Source: Adobe Stock

“We are absolutely delighted to welcome you to the seventh year of IAS,” Merola said. “I can’t believe it has been 7 years. This is our biggest year yet.”

Merola said despite the challenges presented by COVID-19, work in autoimmune diseases must continue. “For many of us, our workload has gotten heavier,” he said. “We have to continue to meet, engage, learn and advance our own knowledge and advance our fields. It is probably as important a time as any for us to communicate between specialties as our fields increasingly blend together.”

Adam S. Cheifetz, MD
Adam S. Cheifetz

For Adam S. Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center, learning from dermatologists and rheumatologists is an integral component to IAS each year. “We rely more heavily on them than they do on us,” he said, and encouraged attendees to ask questions and interact through the online platforms. “Give us your perspectives and your takes.”

Cheifetz highlighted a roundtable discussion from senior advisers of the IAS on the impact of COVID-19 on autoimmune disease. “This really affects us all,” he said.

The 3-day, “jam-packed” program will also include a debate on therapeutic drug monitoring, psoriatic diseases in the telehealth era, case discussions and pre-recorded talks that dive deep into clinical scenarios, according to Cheifetz.

Mital Patel-Cohen, MD, director of Complex Medical Dermatology at Summit Medical Group in Florham Park, New Jersey, underscored the interactive nature of the conference, despite presenters and attendees being separated by physical distance. “All of the IAS faculty are here, we are engaged, we are ready to address all of your questions, so please do bring them forward,” she said. “We are happy to hear any perspectives you all have to add.”